Trial Profile
Imaging Immune Activation in HIV Infection
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2023
Price :
$35
*
At a glance
- Drugs 18F-F-AraG (Primary)
- Indications HIV infections
- Focus Diagnostic use; Pharmacokinetics
- Sponsors CellSight Technologies
- 27 Sep 2023 Planned End Date changed from 1 Oct 2024 to 1 Nov 2024.
- 27 Sep 2023 Planned primary completion date changed from 1 Oct 2023 to 1 Oct 2024.
- 07 Mar 2022 Planned End Date changed from 1 Oct 2021 to 1 Oct 2024.